These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 38074712)

  • 1. Mapping the value for money of precision medicine: a systematic literature review and meta-analysis.
    Chen W; Wong NCB; Wang Y; Zemlyanska Y; Butani D; Virabhak S; Matchar DB; Prapinvanich T; Teerawattananon Y
    Front Public Health; 2023; 11():1151504. PubMed ID: 38074712
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Assessing the cost-effectiveness of precision medicine: protocol for a systematic review and meta-analysis.
    Chen W; Anothaisintawee T; Butani D; Wang Y; Zemlyanska Y; Wong CBN; Virabhak S; Hrishikesh MA; Teerawattananon Y
    BMJ Open; 2022 Apr; 12(4):e057537. PubMed ID: 35383079
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Testing strategies for Lynch syndrome in people with endometrial cancer: systematic reviews and economic evaluation.
    Stinton C; Jordan M; Fraser H; Auguste P; Court R; Al-Khudairy L; Madan J; Grammatopoulos D; Taylor-Phillips S
    Health Technol Assess; 2021 Jun; 25(42):1-216. PubMed ID: 34169821
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cost-effectiveness of precision diagnostic testing for precision medicine approaches against non-small-cell lung cancer: A systematic review.
    Henderson R; Keeling P; French D; Smart D; Sullivan R; Lawler M
    Mol Oncol; 2021 Oct; 15(10):2672-2687. PubMed ID: 34110679
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Economic and modeling evidence for tuberculosis preventive therapy among people living with HIV: A systematic review and meta-analysis.
    Uppal A; Rahman S; Campbell JR; Oxlade O; Menzies D
    PLoS Med; 2021 Sep; 18(9):e1003712. PubMed ID: 34520463
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Exploring the cost-effectiveness of child dental caries prevention programmes. Are we comparing apples and oranges?
    Anopa Y; Conway DI
    Evid Based Dent; 2020 Mar; 21(1):5-7. PubMed ID: 32221482
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Defining the optimum strategy for identifying adults and children with coeliac disease: systematic review and economic modelling.
    Elwenspoek MM; Thom H; Sheppard AL; Keeney E; O'Donnell R; Jackson J; Roadevin C; Dawson S; Lane D; Stubbs J; Everitt H; Watson JC; Hay AD; Gillett P; Robins G; Jones HE; Mallett S; Whiting PF
    Health Technol Assess; 2022 Oct; 26(44):1-310. PubMed ID: 36321689
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The future of Cochrane Neonatal.
    Soll RF; Ovelman C; McGuire W
    Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The clinical effectiveness and cost-effectiveness of home-based, nurse-led health promotion for older people: a systematic review.
    Tappenden P; Campbell F; Rawdin A; Wong R; Kalita N
    Health Technol Assess; 2012; 16(20):1-72. PubMed ID: 22490205
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Net Benefit of Personalized Medicine: A Systematic Literature Review and Regression Analysis.
    Vellekoop H; Versteegh M; Huygens S; Corro Ramos I; Szilberhorn L; Zelei T; Nagy B; Tsiachristas A; Koleva-Kolarova R; Wordsworth S; Rutten-van Mölken M;
    Value Health; 2022 Aug; 25(8):1428-1438. PubMed ID: 35248467
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oral splints for patients with temporomandibular disorders or bruxism: a systematic review and economic evaluation.
    Riley P; Glenny AM; Worthington HV; Jacobsen E; Robertson C; Durham J; Davies S; Petersen H; Boyers D
    Health Technol Assess; 2020 Feb; 24(7):1-224. PubMed ID: 32065109
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Behavioural modification interventions for medically unexplained symptoms in primary care: systematic reviews and economic evaluation.
    Leaviss J; Davis S; Ren S; Hamilton J; Scope A; Booth A; Sutton A; Parry G; Buszewicz M; Moss-Morris R; White P
    Health Technol Assess; 2020 Sep; 24(46):1-490. PubMed ID: 32975190
    [TBL] [Abstract][Full Text] [Related]  

  • 14. EarlyCDT Lung blood test for risk classification of solid pulmonary nodules: systematic review and economic evaluation.
    Duarte A; Corbett M; Melton H; Harden M; Palmer S; Soares M; Simmonds M
    Health Technol Assess; 2022 Dec; 26(49):1-184. PubMed ID: 36534989
    [TBL] [Abstract][Full Text] [Related]  

  • 15. How are we evaluating the cost-effectiveness of companion biomarkers for targeted cancer therapies? A systematic review.
    Seo MK; Cairns J
    BMC Cancer; 2021 Sep; 21(1):980. PubMed ID: 34470603
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A rapid and systematic review of the clinical effectiveness and cost-effectiveness of topotecan for ovarian cancer.
    Forbes C; Shirran L; Bagnall AM; Duffy S; ter Riet G
    Health Technol Assess; 2001; 5(28):1-110. PubMed ID: 11701100
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Denosumab, raloxifene, romosozumab and teriparatide to prevent osteoporotic fragility fractures: a systematic review and economic evaluation.
    Davis S; Simpson E; Hamilton J; James MM; Rawdin A; Wong R; Goka E; Gittoes N; Selby P
    Health Technol Assess; 2020 Jun; 24(29):1-314. PubMed ID: 32588816
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Digital interventions in mental health: evidence syntheses and economic modelling.
    Gega L; Jankovic D; Saramago P; Marshall D; Dawson S; Brabyn S; Nikolaidis GF; Melton H; Churchill R; Bojke L
    Health Technol Assess; 2022 Jan; 26(1):1-182. PubMed ID: 35048909
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quantifying the Impact of Capacity Constraints in Economic Evaluations: An Application in Precision Medicine.
    Wright SJ; Newman WG; Payne K
    Med Decis Making; 2022 May; 42(4):538-553. PubMed ID: 34694170
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Biomarkers for assessing acute kidney injury for people who are being considered for admission to critical care: a systematic review and cost-effectiveness analysis.
    Brazzelli M; Aucott L; Aceves-Martins M; Robertson C; Jacobsen E; Imamura M; Poobalan A; Manson P; Scotland G; Kaye C; Sawhney S; Boyers D
    Health Technol Assess; 2022 Jan; 26(7):1-286. PubMed ID: 35115079
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.